<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00802204</url>
  </required_header>
  <id_info>
    <org_study_id>IRB#080861 and 061246</org_study_id>
    <nct_id>NCT00802204</nct_id>
  </id_info>
  <brief_title>Dopamine and Insulin Resistance</brief_title>
  <official_title>Dopamine Receptor Availability and Insulin Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obese individuals have fewer striatal dopamine type 2 receptors (DRD2) than normal weight
      individuals. Lower DRD2 levels are associated with addiction and a decreased sense of
      pleasure.Obesity is also associated with insulin resistance (poor insulin action).We propose
      that insulin resistance and low DRD2 are associated. Using PET imaging,we aim to determine
      DRD2 binding potential (BP) in the brain is associated with insulin resistance and
      neuroendocrine hormone levels. Obese participants will be compared to lean, gender and age
      similar participants. We also aim to determine the effect of caloric restriction on DRD2 BP
      in obese subjects
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In has been reported obese individuals have fewer striatal dopamine type 2 receptors (DRD2)
      compared to normal weight individuals congruent with diet induced obese rodent models and
      similar to models of addiction. Lower DRD2 levels are associated with addiction and a
      decreased sense of pleasure. Excessive weight gain also contributes to the onset of impaired
      insulin signaling (insulin resistance). In the brain insulin regulates monoamines and has
      trophic effects. We propose that the previous reports of low DRD2 in individuals with obesity
      will be associated with the degree of insulin resistance. Using PET imaging, we aim to
      determine DRD2 binding potential (BP) in the striatum and hypothesize these measurements will
      be associated with insulin resistance and potentially other neuroendocrine hormone levels.
      Obese participants will be compared to lean, sex and age similar participants. We also aim to
      determine the effect of caloric restriction on DRD2 BP in obese subjects. We hypothesize the
      caloric restriction will improve insulin resistance and that changes in DRD2 binding will be
      associated with changes in insulin signaling.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Lean who are age and sex similar to obese will complete baseline outcome measurements only.
Obese will complete baseline outcome measurements then the VLCD intervention with post outcome measurements .</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Striatal DRD2 Receptor Binding</measure>
    <time_frame>Baseline and after 8-10days VLCD</time_frame>
    <description>Region of interest compared to reference region to calculate binding potential</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin</measure>
    <time_frame>Baseline to post 8-10days after VLCD</time_frame>
    <description>microU/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glucose</measure>
    <time_frame>Baseline to post 8-10days after VLCD</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Leptin</measure>
    <time_frame>Baseline to post 8-10days after VLCD</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Acyl Ghrelin</measure>
    <time_frame>Baseline to post 8-10days after VLCD</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin Sensitivity From Oral Glucose Tolerance Test (OGTT_SI)</measure>
    <time_frame>Baseline to post 8-10days after VLCD</time_frame>
    <description>Insulin Sensitivity from Oral Glucose Tolerance Test was estimated using the minimal model method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Binge Eating Score Questionnaire</measure>
    <time_frame>Baseline</time_frame>
    <description>Increased scores indicate increased binge eating behaviors. Score 0-46</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Lean controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lean complete baseline outcome measures only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Obese completing baseline and post-VLCD outcome measures</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>PET scan</intervention_name>
    <description>Both lean and obese undergo a PET scan of the brain using the radioligand,fallypride [18F] at baseline. Obese subjects who complete caloric restriction will have repeat scan after diet.
Completed at baseline and post-VLCD</description>
    <arm_group_label>Lean controls</arm_group_label>
    <arm_group_label>Obese</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oral glucose tolerance test</intervention_name>
    <description>Subjects will be required to drink a glucose solution; blood samples will be taken over a 5-hour time period Completed at baseline by both lean and obese and in obese post-VLCD</description>
    <arm_group_label>Lean controls</arm_group_label>
    <arm_group_label>Obese</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>An MRI of the brain and abdomen will be performed prior to PET scan One time at baseline in both lean and obese</description>
    <arm_group_label>Lean controls</arm_group_label>
    <arm_group_label>Obese</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychological scales to assess attitudes and behaviors related to eating and quality of life</intervention_name>
    <description>A series of short psychological scales will be administered during the study. Completed at baseline</description>
    <arm_group_label>Lean controls</arm_group_label>
    <arm_group_label>Obese</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Caloric Restriction</intervention_name>
    <description>Obese participants only complete a short-term (~10days) very low calorie diet</description>
    <arm_group_label>Obese</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18-60 yrs

          -  obese BMI &gt; 30kg/m2 and Weight less than 350 lbs

          -  lean control BMI 18-25kg/m2

        Exclusion Criteria:

          -  Structured exercise &gt; equivalent to 30mins 5x week of walking times a week

          -  History of Substance Abuse, including but exclusive to alcohol, cocaine, marijuana,
             heroin, nicotine

          -  Current psychiatric disorder or significant h/o disorder

          -  Use or any antidepressants or antipsychotics for last 3-6months or depot
             antipsychotics in the last 12 months

          -  Any condition felt by PI or co-investigators to interfere with ability to complete the
             study

          -  Inability to abstain from alcohol, physical exercise or &gt; 1 cup of coffee or
             equivalent daily for 3 days prior to imaging studies

          -  Significant co-morbidities including atherosclerotic disease, metabolic disease, liver
             or renal insufficiency or abnormality found on MRI

          -  Any condition which would interfere with MRI or PET studies, e.g. claustrophobia,
             cochlear implant, metal fragments in eyes, cardiac pacemaker, neural stimulator,
             tattoos with iron pigment and metallic body inclusions or other metal implanted in the
             body which may interfere with MRI scanning

          -  Subjects on medications determined by PI, ex. sibutramine, frequent benzodiazepines or
             related drugs, which could affect quality of study for last 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia P Dunn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert M Kessler, MD</last_name>
    <role>Study Director</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2008</study_first_submitted>
  <study_first_submitted_qc>December 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2008</study_first_posted>
  <results_first_submitted>July 14, 2016</results_first_submitted>
  <results_first_submitted_qc>March 29, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 10, 2017</results_first_posted>
  <last_update_submitted>March 29, 2017</last_update_submitted>
  <last_update_submitted_qc>March 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Julia P.Dunn,MD</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Neuroendocrine regulation</keyword>
  <keyword>Eating behaviors</keyword>
  <keyword>Dopamine signaling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Dopamine Agents</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>9 lean enroll but only 8 complete. The lean complete study after baseline outcome measurements.
19 obese enroll but only 18 complete baseline outcome measurements and of these 15 completed the VLCD and post-outcome measurements</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Lean</title>
          <description>BMI&lt;~25kg/m2</description>
        </group>
        <group group_id="P2">
          <title>Obese</title>
          <description>BMI&gt;/=30kg/m2</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Lean</title>
        </group>
        <group group_id="B2">
          <title>Obese</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41" spread="9"/>
                    <measurement group_id="B2" value="39" spread="8"/>
                    <measurement group_id="B3" value="39" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>African American Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" spread="7"/>
                    <measurement group_id="B2" value="104" spread="17"/>
                    <measurement group_id="B3" value="91" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23" spread="2"/>
                    <measurement group_id="B2" value="39" spread="6"/>
                    <measurement group_id="B3" value="33" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beck Depression Inventory II(BDI-II)</title>
          <description>0-63 with higher scores indicating increased depressive symptoms. Scores above 20 indicate moderate depressive symptoms.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" spread="5"/>
                    <measurement group_id="B2" value="7" spread="6"/>
                    <measurement group_id="B3" value="6" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>OGTT_SI (Insulin Sensitivity from OGTT)</title>
          <description>Insulin Sensitivity from Oral Glucose Tolerance Test was estimated using the oral minimal model method</description>
          <units>(10-4min-1/µU*mL)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.2" spread="4.1"/>
                    <measurement group_id="B2" value="3.98" spread="2.7"/>
                    <measurement group_id="B3" value="6" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Insulin</title>
          <units>(µU/ml)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6" spread="2"/>
                    <measurement group_id="B2" value="18" spread="9"/>
                    <measurement group_id="B3" value="14" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glucose</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82" spread="6"/>
                    <measurement group_id="B2" value="87" spread="9"/>
                    <measurement group_id="B3" value="86" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Leptin</title>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13" spread="5"/>
                    <measurement group_id="B2" value="43" spread="12"/>
                    <measurement group_id="B3" value="34" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Acyl Ghrelin</title>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="235" spread="104"/>
                    <measurement group_id="B2" value="78" spread="55"/>
                    <measurement group_id="B3" value="132" spread="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Striatal DRD2 Receptor Binding</title>
        <description>Region of interest compared to reference region to calculate binding potential</description>
        <time_frame>Baseline and after 8-10days VLCD</time_frame>
        <population>Baseline outcome measurements are compared between lean and obese. Baseline and post outcome measurements are compared for the obese who completed VLCD</population>
        <group_list>
          <group group_id="O1">
            <title>Lean Baseline</title>
          </group>
          <group group_id="O2">
            <title>Obese Baseline</title>
          </group>
          <group group_id="O3">
            <title>Obese Post-diet</title>
          </group>
        </group_list>
        <measure>
          <title>Striatal DRD2 Receptor Binding</title>
          <description>Region of interest compared to reference region to calculate binding potential</description>
          <population>Baseline outcome measurements are compared between lean and obese. Baseline and post outcome measurements are compared for the obese who completed VLCD</population>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>caudate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" spread="3"/>
                    <measurement group_id="O2" value="33" spread="3"/>
                    <measurement group_id="O3" value="32" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>putamen</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" spread="3"/>
                    <measurement group_id="O2" value="38" spread="3"/>
                    <measurement group_id="O3" value="36" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ventral striatum</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19" spread="4"/>
                    <measurement group_id="O2" value="22" spread="3"/>
                    <measurement group_id="O3" value="22" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Baseline outcome measurements are compared between lean and obese. Baseline and post outcome measurements are compared for the obese who completed VLCD</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>describe.....</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Paired t-test to compare baseline and post-diet outcome measures</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Insulin</title>
        <description>microU/ml</description>
        <time_frame>Baseline to post 8-10days after VLCD</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lean Baseline</title>
          </group>
          <group group_id="O2">
            <title>Obese Baseline</title>
          </group>
          <group group_id="O3">
            <title>Obese Post-diet</title>
          </group>
        </group_list>
        <measure>
          <title>Insulin</title>
          <description>microU/ml</description>
          <units>microU/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" spread="2"/>
                    <measurement group_id="O2" value="19" spread="10"/>
                    <measurement group_id="O3" value="11" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Glucose</title>
        <time_frame>Baseline to post 8-10days after VLCD</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lean Baseline</title>
          </group>
          <group group_id="O2">
            <title>Obese Baseline</title>
          </group>
          <group group_id="O3">
            <title>Obese Post-diet</title>
          </group>
        </group_list>
        <measure>
          <title>Glucose</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82" spread="6"/>
                    <measurement group_id="O2" value="87" spread="9"/>
                    <measurement group_id="O3" value="81" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Leptin</title>
        <time_frame>Baseline to post 8-10days after VLCD</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lean Baseline</title>
          </group>
          <group group_id="O2">
            <title>Obese Baseline</title>
          </group>
          <group group_id="O3">
            <title>Obese Post-diet</title>
          </group>
        </group_list>
        <measure>
          <title>Leptin</title>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" spread="5"/>
                    <measurement group_id="O2" value="43" spread="12"/>
                    <measurement group_id="O3" value="34" spread="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Acyl Ghrelin</title>
        <time_frame>Baseline to post 8-10days after VLCD</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lean Baseline</title>
          </group>
          <group group_id="O2">
            <title>Obese Baseline</title>
          </group>
          <group group_id="O3">
            <title>Obese Post-diet</title>
          </group>
        </group_list>
        <measure>
          <title>Acyl Ghrelin</title>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="235" spread="104"/>
                    <measurement group_id="O2" value="78" spread="55"/>
                    <measurement group_id="O3" value="59" spread="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Insulin Sensitivity From Oral Glucose Tolerance Test (OGTT_SI)</title>
        <description>Insulin Sensitivity from Oral Glucose Tolerance Test was estimated using the minimal model method</description>
        <time_frame>Baseline to post 8-10days after VLCD</time_frame>
        <population>9 lean enroll but only 8 complete. A ll lean complete study after baseline outcome measurements.
19 obese enroll but only 18 complete baseline studies and of these 15 completed the VLCD</population>
        <group_list>
          <group group_id="O1">
            <title>Lean Baseline</title>
          </group>
          <group group_id="O2">
            <title>Obese Baseline</title>
          </group>
          <group group_id="O3">
            <title>Obese Post-diet</title>
          </group>
        </group_list>
        <measure>
          <title>Insulin Sensitivity From Oral Glucose Tolerance Test (OGTT_SI)</title>
          <description>Insulin Sensitivity from Oral Glucose Tolerance Test was estimated using the minimal model method</description>
          <population>9 lean enroll but only 8 complete. A ll lean complete study after baseline outcome measurements.
19 obese enroll but only 18 complete baseline studies and of these 15 completed the VLCD</population>
          <units>10-4*min-1*microU-1*mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" spread="4"/>
                    <measurement group_id="O2" value="4" spread="3"/>
                    <measurement group_id="O3" value="4" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binge Eating Score Questionnaire</title>
        <description>Increased scores indicate increased binge eating behaviors. Score 0-46</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lean</title>
          </group>
          <group group_id="O2">
            <title>Obese</title>
          </group>
        </group_list>
        <measure>
          <title>Binge Eating Score Questionnaire</title>
          <description>Increased scores indicate increased binge eating behaviors. Score 0-46</description>
          <units>score from questionnaire</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" spread="6"/>
                    <measurement group_id="O2" value="12" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Lean</title>
        </group>
        <group group_id="E2">
          <title>Obese</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Julia Dunn, MD</name_or_title>
      <organization>Vanderbilt University</organization>
      <phone>615-343-8389</phone>
      <email>julia.dunn@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

